Laura G Sánchez-Lozada Selected Research

Oxonic Acid

10/2008	Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
4/2008	Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
1/2008	Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.
1/2005	Hemodynamics of hyperuricemia.
1/2005	Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
11/2002	Mild hyperuricemia induces glomerular hypertension in normal rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura G Sánchez-Lozada Research Topics

Disease

22	Hypertension (High Blood Pressure) 08/2023 - 10/2001
15	Hyperuricemia 01/2023 - 11/2002
9	Inflammation (Inflammations) 01/2023 - 03/2003
8	Obesity 10/2023 - 10/2007
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2007
7	Dehydration (Water Stress) 01/2020 - 08/2014
7	Chronic Renal Insufficiency 01/2018 - 01/2006
6	Proteinuria 11/2008 - 10/2001
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2006
4	Fibrosis (Cirrhosis) 01/2018 - 10/2001
3	Hypertrophy 08/2023 - 01/2007
3	Essential Hypertension 08/2023 - 07/2005
3	Kidney Diseases (Kidney Disease) 10/2016 - 10/2007
3	Fatty Liver 11/2013 - 02/2010
3	Non-alcoholic Fatty Liver Disease 11/2013 - 02/2010
2	Insulin Resistance 01/2023 - 01/2022
2	Hyponatremia 01/2023 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2016 - 01/2016
1	Vascular Remodeling 08/2023
1	Body Weight (Weight, Body) 08/2023
1	Hypoxia (Hypoxemia) 08/2023
1	Heart Failure 08/2023
1	Pulmonary Arterial Hypertension 08/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Inappropriate ADH Syndrome (SIADH) 01/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Asthma (Bronchial Asthma) 12/2022
1	Hypovolemia 11/2019
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Chronic Kidney Diseases of Uncertain Etiology 01/2016
1	Crystalluria 01/2016
1	Overnutrition 06/2015

Drug/Important Bio-Agent (IBA)

22	FructoseIBA 10/2023 - 01/2007
15	Uric Acid (Urate)IBA 01/2023 - 01/2005
7	SaltsIBA 08/2023 - 07/2005
7	SugarsIBA 08/2023 - 10/2007
6	Oxonic AcidIBA 10/2008 - 11/2002
5	SodiumIBA 01/2023 - 01/2005
5	Urate Oxidase (Uricase)IBA 10/2022 - 01/2005
5	fructokinaseIBA 01/2020 - 03/2012
4	AntioxidantsIBA 08/2023 - 01/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2010
4	polyolIBA 01/2022 - 08/2014
4	Sucrose (Saccharose)IBA 05/2017 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2003
3	allicinIBA 08/2023 - 01/2016
3	Vasopressins (Vasopressin)IBA 01/2023 - 01/2017
3	Xanthine OxidaseIBA 04/2008 - 01/2008
3	Febuxostat FDA Link 04/2008 - 01/2008
3	Allopurinol (Remid)FDA LinkGeneric 04/2008 - 11/2002
2	Insulin (Novolin)FDA Link 10/2023 - 04/2008
2	Adenosine Triphosphate (ATP)IBA 10/2023 - 01/2012
2	CarbohydratesIBA 10/2023 - 05/2017
2	InflammasomesIBA 01/2023 - 01/2018
2	CreatinineIBA 01/2017 - 08/2014
2	Angiotensin IIIBA 01/2016 - 10/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2013 - 02/2010
2	EnzymesIBA 11/2013 - 11/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 02/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008 - 04/2007
2	Drinking WaterIBA 04/2008 - 01/2007
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2003 - 03/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023
1	Antihypertensive Agents (Antihypertensives)IBA 08/2023
1	Sodium Chloride FDA LinkGeneric 08/2023
1	GlycogenIBA 01/2023
1	DiureticsIBA 01/2023
1	AntibodiesIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Therapeutic UsesIBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	Antiviral Agents (Antivirals)IBA 12/2022
1	Sulfur Compounds (Compounds, Sulfur)IBA 12/2022
1	SirtuinsIBA 01/2022
1	NAD (NADH)IBA 01/2022
1	AcidsIBA 11/2019
1	High Fructose Corn SyrupIBA 05/2017
1	conivaptan (Vaprisol)FDA Link 01/2017
1	Potassium Chloride FDA LinkGeneric 01/2017
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2017
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	Free RadicalsIBA 01/2016
1	Potassium Iodide (Pima)FDA Link 06/2015
1	CollagenIBA 11/2013
1	Protein Isoforms (Isoforms)IBA 03/2012
1	Adenylate KinaseIBA 01/2012
1	Adenosine Monophosphate (AMP)IBA 01/2012
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	AMP-Activated Protein Kinase KinasesIBA 01/2012
1	AMP Deaminase (Myoadenylate Deaminase)IBA 01/2012
1	AMP-Activated Protein KinasesIBA 01/2012

Therapy/Procedure

4	Nephrectomy 01/2008 - 10/2001
3	Punctures 01/2005 - 06/2002
2	Therapeutics 01/2016 - 06/2010
1	Fluid Therapy (Oral Rehydration Therapy) 01/2018
1	Fat-Restricted Diet (Diet, Fat Restricted) 11/2013